Investments in and Advances to Joint Ventures (Tables)

3 Months Ended

Mar. 31, 2023

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Financial Information of Consolidated Joint Ventures

The following represents financial information for consolidated joint ventures included in the consolidated financial statements (in thousands):

	March 31, 2023		December 31, 2022
Current assets	$	331,742	$	289,837
Noncurrent assets		10,693		9,961
Total assets		342,435		299,798
Current liabilities		216,682		194,701
Noncurrent liabilities		3,871		3,763
Total liabilities		220,553		198,464
Total joint venture equity	$	121,882	$	101,334

	Three Months Ended
	March 31, 2023		March 31, 2022
Revenue	$	161,484	$	95,534
Costs		141,598		88,842
Net income	$	19,886	$	6,692
Net income attributable to noncontrolling interests	$	9,723	$	3,176

Summary of Financial Information for Unconsolidated Joint Ventures

The following represents the financial information of the Company’s unconsolidated joint ventures as presented in their unaudited financial statements (in thousands):

	March 31, 2023		December 31, 2022
Current assets	$	1,291,910	$	1,610,246
Noncurrent assets		493,501		491,658
Total assets		1,785,411		2,101,904
Current liabilities		848,105		1,255,297
Noncurrent liabilities		540,967		468,056
Total liabilities		1,389,072		1,723,353
Total joint venture equity	$	396,339	$	378,551
Investments in and advances to unconsolidated joint ventures	$	107,416	$	107,425

	Three Months Ended
	March 31, 2023			March 31, 2022
Revenue	$	349,157		$	384,581
Costs		359,395			373,286
Net income	$	(10,238	)	$	11,295
Equity in (losses) earnings of unconsolidated joint ventures	$	(5,840	)	$	5,598